This topic contains a solution. Click here to go to the answer

Author Question: Applying drugs that act as antagonists at the NMDA glutamate receptor before spatial learning occurs ... (Read 42 times)

Chelseaamend

  • Hero Member
  • *****
  • Posts: 545
Applying drugs that act as antagonists at the NMDA glutamate receptor before spatial learning occurs interferes with
 
  a. both LTP and spatial memory acquisition.
 b. neither LTP nor spatial memory acquisition.
 c. LTP, but not with spatial memory acquisition.
 d. spatial memory, but not with LTP.

Question 2

Mice with regular long-term potentiation (LTP)
 
  a. are unable to form spatial maps.
 b. form spatial maps that are inaccurate.
 c. form spatial maps accurately but experience immediate loss of those maps.
 d. form new maps and can retain them for long periods of time.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

amy.lauersdorf90

  • Sr. Member
  • ****
  • Posts: 327
Answer to Question 1

a

Answer to Question 2

d




Chelseaamend

  • Member
  • Posts: 545
Reply 2 on: Jun 21, 2018
Excellent


mochi09

  • Member
  • Posts: 335
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

A headache when you wake up in the morning is indicative of sinusitis. Other symptoms of sinusitis can include fever, weakness, tiredness, a cough that may be more severe at night, and a runny nose or nasal congestion.

Did you know?

Drug-induced pharmacodynamic effects manifested in older adults include drug-induced renal toxicity, which can be a major factor when these adults are experiencing other kidney problems.

Did you know?

Vital signs (blood pressure, temperature, pulse rate, respiration rate) should be taken before any drug administration. Patients should be informed not to use tobacco or caffeine at least 30 minutes before their appointment.

Did you know?

Patients who cannot swallow may receive nutrition via a parenteral route—usually, a catheter is inserted through the chest into a large vein going into the heart.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library